Navigation Links
United States Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts Report 2015-2020
Date:10/27/2015

DUBLIN, Oct. 27, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/46g6v5/2015_us_hospital) has announced the addition of the "2015 US Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review" report to their offering.

This new report contains 543 pages, 63 tables, and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including:

  • Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years
  • Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, including controls, calibrators and consumables
  • Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens
  • Five-year reagent and instrument sales forecasts
  • Review of current instrumentation technologies, and a feature comparison of high-, medium-, and low-volume/POC analyzers
  • Sales and market shares of leading reagent and instrument suppliers
  • Review of current and emerging technologies and their potential market applications
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies
  • Market penetration strategies, entry barriers and risks

Companies Mentioned

- Abbott Laboratories
- AdnaGen/Alere
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio
- Grifols
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE

For more information visit http://www.researchandmarkets.com/research/46g6v5/2015_us_hospital

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. United States Cell Surface Marker Testing Market 2015: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities
2. United Therapeutics Corporation Reports Third Quarter 2015 Financial Results
3. United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015
4. Menarini and Meyer United In The Search For Rare Cells
5. United Therapeutics Announces Additional $500 Million Share Repurchase Program
6. United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.
7. In'Tech Medical Announces Expansion of its Production-Equivalent Prototype Division, The Prototype Garage, in the United States
8. InSphero Granted Hanging Drop Patent in United States
9. BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health
10. P2i Settles United States Litigation
11. United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... 23, 2017  Agriculture technology company Cool Planet has ... note conversion to commercialize its Cool Terra and Cool ... developing products that are simultaneously profitable as well as ... last 18 months. This latest round of funding was ... The company,s primary product, Cool Terra, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... March 22, 2017  UBM and the Massachusetts ... their extended partnership and the third annual Massachusetts Medtech ... the 21 st Annual MassMEDIC Conference held ... May 3-4, 2017. MassMEDIC will ... (ADVAMED) President and CEO, Scott Whitaker , ...
Breaking Biology Technology:
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):